Clinical Trials Logo

Clinical Trial Summary

The primary objectives of this study are to describe the efficacy of:

1. 8-week treatment of SOF/LED for treatment-naïve, non-cirrhotic, HCV genotype 6

2. 12-week treatment of SOF/LED for all other HCV-6 populations


Clinical Trial Description

The secondary objective of this study is to describe safety, persistency, and tolerability of SOF/LED in patients with HCV-6. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02480166
Study type Interventional
Source Stanford University
Contact
Status Completed
Phase Phase 4
Start date June 2015
Completion date October 2016

See also
  Status Clinical Trial Phase
Withdrawn NCT02485080 - Safety, Tolerability, and Efficacy of 24 Weeks Simeprevir+Sofosbuvir for Chronic Hepatitis C Genotype 1 Phase 4